Event Content

In this session, Aaron Dely, Vice President of R&D at PLD Pharma Services, explores the opportunities and challenges of developing over-the-counter (OTC) and Rx gummies. Dely explains why consumer demand for gummies—driven by improved compliance—is fueling rapid growth and premium pricing in this dosage fo...

Explore how predictive modeling can be integrated across the injector development lifecycle—from design and usability testing to regulatory submissions. This session highlights how modeling supports risk reduction, regulatory confidence, and faster market access.

Wearable devices that monitor vital signs, physical activity, and other health metrics are now utilized by approximately one in three individuals for tracking personal health and wellness. Despite their evident advantages, the integration and widespread adoption of connected devices within the healthcare s...

ReciBioPharm introduces an advanced process analytical technology (PAT) platform for RNA therapeutics that leverages in-line PAT and machine learning to enable real-time monitoring, control, and optimization. PAT tools provide continuous data throughout the production process—from plasmid linearization to ...

Pharmaceutical supply chains have evolved into a global ecosystem to optimize costs, volumes and capacities, and environmental regulations. However, there are still many vulnerabilities that make them unreliable, unpredictable, and unable to support the needs of a growing population.
Biomanufactur...

Healthcare is undergoing a vital shift from a one-size-fits-all model to more personalized, precise, and patient-centered care. To keep pace, clinical trials also need to adopt a scalable, adaptive approach that better aligns with individual patient needs and real-world complexities.
By incorporati...

• Alternative Approaches to Boost Patient Enrolment Amid Recruitment Challenges • How the Rising Pressures of Patient Recruitment Are Challenging Traditional Enrolment Methods

Bringing a molecule to market is challenging, especially under tight timelines, limited budgets, and the constraints of sensitive and costly materials. Traditional process development and scale-up often relies on manual work, consuming significant resources and offering limited insights into CMAs~CPPs~CQAs...

Subcutaneous injection is one of the most common routes of administration for biologic drugs to treat chronic diseases. While subcutaneous administration can improve patient compliance and quality of life by enabling at-home injections as compared to intravenous or intramuscular route, the associated anxie...

Did you know that the healthcare industry contributes to approximately 5% of global GHG emissions? • To tackle this challenge, healthcare and pharmaceutical companies need to strengthen their focus on sustainability and circularity. Preparing for the Packaging and Packaging Waste Regulation (PPWR) is ...

Often, sustainability and efficiency are hindered by the perception that other actors in the supply chain are not fulfilling their roles effectively. This panel will bring together key stakeholders from across the entire pharmaceutical supply chain. Participants will engage in an honest dialogue, sharing t...

Today’s practice of single-use plastic packaging in pharma industry is a waste and emission driver consuming finite resources. As of today, virgin material is applied to ensure patient safety resulting in large quantities of waste. Three pharma pioneers addressed this issue led by the question: How to over...

Ensuring accurate potency testing and maintaining product purity are crucial in antibody-drug conjugate (ADC) development, scale-up, and commercialization. Innovative solutions, including effective tools and streamlined processes, are necessary for efficient production of ADCs for clinical trials and comme...

In pharmaceutical manufacturing, operational efficiency is crucial for meeting production targets while ensuring product quality and reducing manufacturing cost. One impactful strategy is increasing the number of cavities per nest for prefilable polymer syringes. This enhancement maximizes conveyor space u...

Join our panel of experts as we delve into the latest innovations and advancements in academia, exploring how these developments can benefit the biologics industry.

Join us for a series of rapid-fire talks on disruptive manufacturing technologies. • AI - Unleashing the potential of AI in pharmaceutical manufacturing to streamline processes, enhance efficiency, and ensure product quality • Advanced Manufacturing - Delving into the latest advanced manufacturing ...

The growing awareness of the environmental and health risks associated with (PFAS) has led to a global movement to phase out these chemicals from various products. In the pharmaceutical industry, PFAS have been used in some excipients due to their unique properties but concerns about potential health effe...

Reviewing the outcome of the inflation reduction act and how it is affecting pharmaceutical manufacturers and distributors in managing drug pricing within the supply chain, including:
Examining broader economic and market trends influencing drug pricing within the supply chain economy and their eff...

In this workshop, we focus on achieving both environmental sustainability and patient well-being through innovative pharmaceutical packaging. Aligned with Berry Global’ s dedication to sustainability and innovation, we will discuss practical strategies for creating sustainable medical and pharmaceutica...

Numerous drug technologies are advancing into pre-clinical and early clinical phases to enable new therapies with improved health outcomes. Those new technologies carry potential challenges pertaining to their compatibility with the container materials and with environmental conditions such as temperature ...

Drug development, particularly of biologics can be expensive and run over several years. One of the challenges for formulation and clinical development teams is identifying devices for use in early formulation and clinical studies, where the performance characteristics and clinical safety are being assesse...

Digital health solutions create myriad possibilities in terms of enabling “beyond the pill” health outcomes. However, the path to streamlining a strategic approach between pharma and its development partners toward creating smart combination products remains a challenge. With a general consensus that devel...

mRNA vaccines helped us through the COVID-19 pandemic — but they could also help defend against many other infectious diseases. Join Moderna to understand how mRNA can play a key role in future therapies.
• Learnings from the COVID-19 vaccine and translating mRNA technology to other therapy areas...

The complexity and risks found within the global pharma supply chain cannot be understated and key stakeholders from customers to regulators, and investors are increasingly expecting the industry to both manage ESG risks and embed sustainability throughout the value chain.
This can only be achieved ...

Technology is playing an ever-greater role in life sciences, and new ways of working in automation and supply chain. Join our panel of experts where they will delve into what is required in developing a new standard for manufacturing quality • Focus on business and patient outcomes over te...

GELITA introduces its latest innovation EASYSEAL®: a pharmaceutical grade Softgel gelatin, that improves capsule seams and helps Softgel manufacturers to • Significantly reduce leaking Softgels • Manufacture with higher machine speed • Increase Yield • Reduce production costs • Enable fil...

With the industry shifting to become more sustainable, it is crucial for both end-users and vendors to work together when sourcing greener raw materials. Join and learn about the need for global collaboration and what you can do to adopt green chemistry practices to your business: • Assessing the curr...

Where QBD was the orchestral sheet music that determined how drug product development has been harmonized over the last 15 or so years, contemporary patient-centric risk-based approaches to drug development are the pop evolution. The music is still beautiful when produced well - but the focus is no longer...

Manufacturers face unique quality challenges that can hinder progress. In this session hear about quality challenges in Cell and Gene Therapy (CGT) and learn common practices for overcoming them: • The amc was formed in 2010 to focus on manufacturing when everything at the time was focused on clinical...

Where QBD was the orchestral sheet music that determined how drug product development has been harmonized over the last 15 or so years, contemporary patient-centric risk-based approaches to drug development are the pop evolution. The music is still beautiful when produced well - but the focus is no longer...

• Market needs for a device to deliver high drug loads to lungs. • Introduction to the Orbital device – features and benefits. • Comparative performance of Orbital to other DPI devices. • Different types of molecules and formulations made using different particle engineering technologies, inc...

New therapeutic treatments or prophylactic vaccines rely on more complicated drug formulations, often based on biologics. These drugs are highly sensitive and might require low temperature storage to keep them stable over shelf life. These extreme cold supply chain processes, something up to -80°C, provide...

The presentation will look in some detail how aging / stability studies are established and address the following • What is aging / stability? • What is purpose of aging / stability testing? • What about relative humidity? • What risks are involved? • How long is the shelf life of your prod...

Advances in auto-injector design now provide the option to use both 1ml and 2.25mL syringes plus employ technology to adapt to varying fill volumes and viscosities all whilst maintaining the same device form. This provides a solution for the formulation changes that take place during drug development, clin...

Nutraceuticals and over-the-counter (OTC) products are regulated by EFSA. The European Food Safety Authority (EFSA) states that human intervention studies are ‘central’ to health claim substantiation and are also the ‘top of the hierarchy’ that informs decisions. Just how much data is necessary to deliver ...

Have you wondered what value digital health brings to health systems?

This session will cover the ~25 main digital health value pools on health system level and show what value digital health solutions provide. In addition, digital health reimbursement is addressed, with a particular focus on t...

On Demand Pharmaceuticals is creating technology platforms that enable point-of-care medicine manufacturing whether on the battlefield or hospital. By building modular automated systems that can produce raw materials to finished drug product, we are strengthening medicine supply chain resiliency and transf...

Antheia is a synthetic biology company developing rapid-response biomanufacturing processes for Active Pharmaceutical Ingredients and Key Starting Materials. In this session, Christina Smolke, PhD, CEO and co-founder of Antheia will dive into synthetic biology as a manufacturing technology and its potentia...

Originally broadcast as part of the CPHI Monthly Podcasts Series Smart devices and their companion apps are transforming the patient experience and moving healthcare management from hospitals to homes. However, this digital shift can prove challenging for some users. In the latest instalment of our p...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Corinne Ondo, Head of Sourcing Production Materials Biotech & Healthcare Innovation, Merck discusses how Healthcare is currently improving packaging reuse in its supply chain by working in close partnership with its suppliers. By...

In this webinar, originally broadcast as a part of Pharmapack Europe 2022, speakers from STERIS will be describing the methodology for transferring the sterilization process of medical or pharma products from one radiation technology to another (e.g. gamma to X-ray).

In this webinar, originally broadcast as part of the Pharmapack Europe show, speakers Michael Earl, Director Pharmaceutical Services, Sian Eden Business Development Manager, Olivia Houselander Business Development Manage, Denis Marteau General Manager, Pharmaceutical Services, Oli Gould Design Team Manager...

Discuss strategies and methodologies to develop scalable, robust, and cost-effective manufacturing processes for allogeneic cell therapies Showcase how induced pluripotent stem cells (iPSC) are being used as renewable sources of allogeneic cancer therapies Demonstrate the criticality of GMP manufacturing...

Talk of bringing back domestic manufacturing to North America has dominated conversations around pharma manufacturing for years, and have been a key talking point in government post-pandemic recovery plans, but how far have we come and who is this really working for? Asian CDMO’s recognizing the trend f...

In this webinar, originally broadcast as part of CPHI North America 2022, Frances Zipp, President and CEO, Lachmann Consultants Services discusses lessons learned and best practices for these relationships that can be applied to both accelerated approvals as well as “normal” drug supply during non-pandemic...

In this webinar, originally broadcast as part of CPHI North America, Marrisa Fayer, Ceo and Founder HerHealthEQ discusses in this session: • Where women are needed more (hint, it's everywhere) • Why having women involved in all aspects of the business makes better business • How to get more women i...